Emmchak Formulations Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 12-12-2024
- Paid Up Capital ₹ 5.00 M
as on 12-12-2024
- Company Age 7 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 5.43 Cr
as on 12-12-2024
- Revenue -6.27%
(FY 2024)
- Profit -73.63%
(FY 2024)
- Ebitda 9.05%
(FY 2024)
- Net Worth
- Total Assets 10.69%
(FY 2024)
About Emmchak Formulations
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 5.00 M.
The company currently has active open charges totaling ₹5.43 Cr.
Saminathan Sivalingam, Sivalingam Subramanian, Chinnasamy Gopi, and One other member serve as directors at the Company.
- CIN/LLPIN
U74999TN2017PTC116636
- Company No.
116636
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
19 May 2017
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Company Details
- Location
Tiruchirappalli, Tamil Nadu, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Emmchak Formulations?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sivalingam Subramanian  | Managing Director | 19-May-2017 | Current |
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Saminathan Sivalingam | Director | 19-May-2017 | Current |
| Chinnasamy Gopi | Director | 19-May-2017 | Current |
| Gopi Sumathi | Director | 19-May-2017 | Current |
Financial Performance of Emmchak Formulations.
Emmchak Formulations Private Limited, for the financial year ended 2024, experienced Minor drop in revenue, with a 6.27% decrease. The company also saw a substantial fall in profitability, with a 73.63% decrease in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth | |||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Emmchak Formulations?
Unlock access to Emmchak Formulations's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Tiruchy Sathya Chits Private LimitedActive 17 years 6 monthsSaminathan Sivalingam is a mutual person
- Trichy Sri Aishwarya Chits Private LimitedActive 9 years 2 months
Sivalingam Subramanian is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 21 Mar 2023 | ₹1.00 M | Open |
Others Creation Date: 07 Mar 2023 | ₹5.00 M | Open |
Others Creation Date: 06 Mar 2023 | ₹3.90 M | Open |
How Many Employees Work at Emmchak Formulations?
Emmchak Formulations has a workforce of 24 employees as of Nov 22, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Emmchak Formulations, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Emmchak Formulations's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
